Kumar Budur - 24 Jan 2025 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Reporting relationship: CHIEF MEDICAL OFFICER
Issuer ticker: HRMY
Reported as of: 24 Jan 2025
Net transaction value: -$43,750
SEC form: 4
Accepted by SEC: 28 Jan 2025, 16:10:18 UTC
Prior SEC filing: 03 May 2024
Next SEC filing: 09 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Christian Ulrich, Attorney-in-Fact

Key filing fact

Kumar Budur filed Form 4 for Harmony Biosciences Holdings, Inc. (HRMY) on 28 Jan 2025.

Key facts

This page summarizes Kumar Budur's Form 4 filing for Harmony Biosciences Holdings, Inc. (HRMY).
5 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 28 Jan 2025, 16:10.

Change

Previous filing in this sequence was filed on 03 May 2024.
Current net transaction value: -$43,750.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HRMY transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +2,187
Change %
Price: $0.000000
Shares after: 2,187
Date: 24 Jan 2025
Ownership: Direct

HRMY transaction

Common Stock

Tax liability

Transaction value: $43,750
Shares: -1,151
Change %: -53%
Price: $38.01
Shares after: 1,036
Date: 24 Jan 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HRMY transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -2,187
Change %: -25%
Price: $0.000000
Shares after: 6,563
Date: 24 Jan 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,187
Exercise price
Footnotes: F2

HRMY transaction Derivative

Stock Option

Award

Transaction value: $0
Shares: +37,400
Change %
Price: $0.000000
Shares after: 37,400
Date: 25 Jan 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 37,400
Exercise price: $38.01
Footnotes: F3

HRMY transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +10,650
Change %
Price: $0.000000
Shares after: 10,650
Date: 25 Jan 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,650
Exercise price
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.

Footnote F2

This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

Footnote F3

The stock option vests with respect to 25% of the underlying shares on January 25, 2026, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

Footnote F4

The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.